Coronavirus Stocks: Pfizer, BioNTech, Mesoblast
Australian biotech Mesoblast (MESO) rocketed 17% on earnings, and on a Covid-19 treatment partnership with Switzerland's Novartis (NVS). Volatile Mesoblast shares have a 60% year-to-date gain, but are down 44% from a late-August high.
This came out tonight on the US Investor business Daily.
Watch this space.
Coronavirus Stocks: Pfizer, BioNTech, MesoblastAustralian...
-
- There are more pages in this discussion • 450 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.12 |
Change
0.015(1.36%) |
Mkt cap ! $1.278B | |||
| Open | High | Low | Value | Volume |
| $1.13 | $1.16 | $1.10 | $7.169M | 6.411M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 7296 | $1.12 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.12 | 43068 | 1 |
View Market Depth
| Last trade - 16.10pm 08/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |